Corporate Banner
Satellite Banner
Pharma Outsourcing
Scientific Community
Become a Member | Sign in
Home>Products>Product News
  Service News
Nanotherapeutics Selects GE Healthcare Life Sciences Technologies
Thursday, February 06, 2014
FlexFactory™ biomanufacturing platform selected to perform a central role in NANO-ADM Center.

Cotton Rat RSV Model Launched by Noble Life Sciences and IBT Bioservices
Friday, January 31, 2014
Cotton rat model for preclinical studies of respiratory syncytial virus therapies and vaccines.

SCHOTT Assists the Pharmaceutical Industry on Tracking Pharmaceutical Tubing
Thursday, January 23, 2014
Company issues its 1 millionth certificate for its FIOLAX® glass tubing.

FDA, EMA Extend Licenses for Aptiv Solutions ADDPLAN® Software
Wednesday, January 08, 2014
FDA purchases novel ADDPLAN® DF Software for improved evaluation of Phase II dose-finding trials.

EyeTechCare Doubles the Number of Health Care Facilities in France with the EyeOP1 Device
Thursday, January 02, 2014
The EyeOp1 device is now available in ten centers across France, with this figure expected to double in 2014.

TELOS MicroPlate™ from Kinesis – a versatile 96-well SPE format for small volume biological fluid samples
Monday, December 16, 2013
The TELOS MicroPlate™ is a versatile 96-well plate for the extraction of drug molecules from small volume biological fluid samples.

New UK mHealth Congress Announced for 2014
Tuesday, November 19, 2013
MCT-Congress will bring together key influencers to drive the business of mHealth in clinical research.

Phenom-World Launches the New Particlemetric Software for Fully Automated Inspection and Analysis of Particles
Tuesday, November 12, 2013
With the introduction of the ParticleMetric software, the visualization and analysis of particles are easier than ever before with the Phenom desktop SEM.

Nov 20 Best Practices IV: Preclinical Outsourcing Program/Simulcast
Monday, November 11, 2013
Preclinical outsourcing program/simulcast at Ocean Place in Long Branch, NJ, and via Webinar.

<< 3 4 5 6 7 8 9 >>
Showing Results 51 - 60 of 312
Scientific News
Lucentis Effective for Proliferative Diabetic Retinopathy
NIH-funded clinical trial marks first major advance in therapy in 40 years.
Blocking the Transmission Of Malaria Parasites
Vaccine candidate administered for the first time in humans in a phase I clinical trial led by Oxford University’s Jenner Institute, with partners Imaxio and GSK.
First Therapy Appearing to Reverse Decline in Parkinson’s
An FDA-approved drug for leukemia improved cognition, motor skills and non-motor function in patients with Parkinson’s disease and Lewy body dementia in a small clinical trial, say researchers at Georgetown University Medical Center (GUMC).
Gene Therapy Staves Off Blindness from Retinitis Pigmentosa in Canine Model
NIH-funded study suggests therapeutic window may extend to later-stage disease.
Treatment for Rare Bleeding Disorder is Effective
Researchers in Manchester have demonstrated for the first time the relative safety and effectiveness of treatment, eltrombopag, in children with persistent or chronic immune thrombocytopenia (ITP), as part of an international duo of studies.
HIV Vaccine Human Trials Begin
Baltimore-based Institute has begun enrolling volunteers for initial phase 1 clinical trials.
New Therapy Reduces Symptoms of Inherited Enzyme Deficiency
A phase three clinical trial of a new enzyme replacement medication, sebelipase alfa, showed a reduction in multiple disease-related symptoms in children and adults with lysosomal acid lipase deficiency, an inherited enzyme deficiency that can result in scarring of the liver and high cholesterol.
Fixing Holes in the Heart Without Invasive Surgery
UV-light enabled catheter is a medical device which represents a major shift in how cardiac defects are repaired.
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
Scroll Up
Scroll Down

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos